Lung transplantation for cystic fibrosis: an update and practical considerations for referring candidates

Curr Opin Pulm Med. 1999 Nov;5(6):365-70. doi: 10.1097/00063198-199911000-00008.


In this article, the authors provide an update to Maurer and Chaparro's 1995 review in this journal of lung transplantation for cystic fibrosis. Bilateral (sequential) cadaver donor transplantation is the usual procedure of choice. The four-year survival rate for adult, all-disease, double-bilateral lung transplantation has improved to 53%. Because of lower [corrected] survival rate among adults, living-donor lobar transplantation should be performed only when cadaver lungs are unlikely to become available. The International Society for Heart and Lung Transplantation and the Cystic Fibrosis Foundation have promulgated uniform guidelines for transplantation candidate selection. Issues of diabetes mellitus, mechanical ventilation, osteoporosis, malnutrition, fungi and drug-resistant bacteria, pleural fibrosis, and sinusitis in relation to transplantation candidacy are discussed. Some practical points regarding transplantation center referral are presented, and a list of cystic fibrosis transplantation centers in the United States is supplied.

Publication types

  • Review

MeSH terms

  • Adult
  • Cadaver
  • Cystic Fibrosis / surgery*
  • Diabetes Complications
  • Drug Resistance, Microbial
  • Fibrosis
  • Humans
  • Living Donors
  • Lung Transplantation*
  • Nutrition Disorders / complications
  • Osteoporosis / complications
  • Patient Selection*
  • Pleura / pathology
  • Practice Guidelines as Topic
  • Referral and Consultation*
  • Respiration, Artificial
  • Sinusitis / complications
  • Survival Rate